Candriam Luxembourg S.C.A. Has $7.68 Million Stake in CVS Health Corporation (CVS)

Candriam Luxembourg S.C.A. lifted its stake in shares of CVS Health Corporation (NYSE:CVS) by 3.6% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 95,453 shares of the pharmacy operator’s stock after purchasing an additional 3,314 shares during the period. Candriam Luxembourg S.C.A.’s holdings in CVS Health Corporation were worth $7,680,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Mercer Capital Advisers Inc. bought a new stake in shares of CVS Health Corporation during the 1st quarter worth approximately $118,000. TB Alternative Assets Ltd. bought a new stake in CVS Health Corporation in the 2nd quarter valued at $121,000. Gemmer Asset Management LLC raised its stake in CVS Health Corporation by 15.3% in the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after acquiring an additional 200 shares during the period. SRS Capital Advisors Inc. raised its stake in CVS Health Corporation by 48.2% in the 1st quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock valued at $177,000 after acquiring an additional 734 shares during the period. Finally, Grace & White Inc. NY bought a new stake in CVS Health Corporation in the 2nd quarter valued at $199,000. Institutional investors own 81.51% of the company’s stock.

In related news, Director Richard J. Swift sold 2,500 shares of the business’s stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $79.62, for a total transaction of $199,050.00. Following the sale, the director now directly owns 3,258 shares in the company, valued at approximately $259,401.96. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO David M. Denton sold 237,078 shares of the business’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $79.65, for a total value of $18,883,262.70. Following the sale, the chief financial officer now owns 141,096 shares in the company, valued at $11,238,296.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 716,625 shares of company stock worth $58,318,431. Corporate insiders own 0.61% of the company’s stock.

A number of equities research analysts recently weighed in on the company. Vetr cut CVS Health Corporation from a “strong-buy” rating to a “buy” rating and set a $88.97 price target on the stock. in a research note on Monday, June 12th. Guggenheim restated a “buy” rating on shares of CVS Health Corporation in a research note on Monday, July 3rd. Needham & Company LLC restated a “hold” rating on shares of CVS Health Corporation in a research note on Sunday, September 10th. Citigroup Inc. dropped their price target on CVS Health Corporation from $88.00 to $87.00 and set a “neutral” rating on the stock in a research note on Thursday, August 17th. Finally, BidaskClub cut CVS Health Corporation from a “hold” rating to a “sell” rating in a research note on Friday, August 25th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and fifteen have assigned a buy rating to the company. CVS Health Corporation currently has an average rating of “Buy” and an average target price of $89.56.

ILLEGAL ACTIVITY WARNING: “Candriam Luxembourg S.C.A. Has $7.68 Million Stake in CVS Health Corporation (CVS)” was first published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://ledgergazette.com/2017/10/09/candriam-luxembourg-s-c-a-has-7-68-million-stake-in-cvs-health-corporation-cvs.html.

CVS Health Corporation (NYSE:CVS) opened at 76.92 on Monday. CVS Health Corporation has a one year low of $69.30 and a one year high of $88.92. The firm has a market capitalization of $78.19 billion, a price-to-earnings ratio of 15.32 and a beta of 0.92. The firm has a 50-day moving average price of $79.64 and a 200-day moving average price of $79.03.

CVS Health Corporation (NYSE:CVS) last issued its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.31 by $0.02. The firm had revenue of $45.69 billion for the quarter, compared to analyst estimates of $45.36 billion. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The business’s revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.32 earnings per share. Analysts expect that CVS Health Corporation will post $5.88 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Monday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.60%. CVS Health Corporation’s payout ratio is presently 39.92%.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the s

Other institutional investors also recently made changes to their positions in the company. Mercer Capital Advisers Inc. bought a new stake in shares of CVS Health Corporation during the 1st quarter worth approximately $118,000. TB Alternative Assets Ltd. bought a new stake in CVS Health Corporation in the 2nd quarter valued at $121,000. Gemmer Asset Management LLC raised its stake in CVS Health Corporation by 15.3% in the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after acquiring an additional 200 shares during the period. SRS Capital Advisors Inc. raised its stake in CVS Health Corporation by 48.2% in the 1st quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock valued at $177,000 after acquiring an additional 734 shares during the period. Finally, Grace & White Inc. NY bought a new stake in CVS Health Corporation in the 2nd quarter valued at $199,000. Institutional investors own 81.51% of the company’s stock.

In related news, Director Richard J. Swift sold 2,500 shares of the business’s stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $79.62, for a total transaction of $199,050.00. Following the sale, the director now directly owns 3,258 shares in the company, valued at approximately $259,401.96. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO David M. Denton sold 237,078 shares of the business’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $79.65, for a total value of $18,883,262.70. Following the sale, the chief financial officer now owns 141,096 shares in the company, valued at $11,238,296.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 716,625 shares of company stock worth $58,318,431. Corporate insiders own 0.61% of the company’s stock.

A number of equities research analysts recently weighed in on the company. Vetr cut CVS Health Corporation from a “strong-buy” rating to a “buy” rating and set a $88.97 price target on the stock. in a research note on Monday, June 12th. Guggenheim restated a “buy” rating on shares of CVS Health Corporation in a research note on Monday, July 3rd. Needham & Company LLC restated a “hold” rating on shares of CVS Health Corporation in a research note on Sunday, September 10th. Citigroup Inc. dropped their price target on CVS Health Corporation from $88.00 to $87.00 and set a “neutral” rating on the stock in a research note on Thursday, August 17th. Finally, BidaskClub cut CVS Health Corporation from a “hold” rating to a “sell” rating in a research note on Friday, August 25th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and fifteen have assigned a buy rating to the company. CVS Health Corporation currently has an average rating of “Buy” and an average target price of $89.56.

ILLEGAL ACTIVITY WARNING: “Candriam Luxembourg S.C.A. Has $7.68 Million Stake in CVS Health Corporation (CVS)” was first published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://ledgergazette.com/2017/10/09/candriam-luxembourg-s-c-a-has-7-68-million-stake-in-cvs-health-corporation-cvs.html.

CVS Health Corporation (NYSE:CVS) opened at 76.92 on Monday. CVS Health Corporation has a one year low of $69.30 and a one year high of $88.92. The firm has a market capitalization of $78.19 billion, a price-to-earnings ratio of 15.32 and a beta of 0.92. The firm has a 50-day moving average price of $79.64 and a 200-day moving average price of $79.03.

CVS Health Corporation (NYSE:CVS) last issued its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.31 by $0.02. The firm had revenue of $45.69 billion for the quarter, compared to analyst estimates of $45.36 billion. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The business’s revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.32 earnings per share. Analysts expect that CVS Health Corporation will post $5.88 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Monday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.60%. CVS Health Corporation’s payout ratio is presently 39.92%.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply